Fish KJ, Sarnquist FH, van Steennis et al.A prospective, randomised study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. J Thorac Cardiovasc Surg1986; 91: 436-42.
2.
Teoh KH, Cristakis GT, Weisel RD et al.Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg1988; 96: 332-41.
3.
Salzman EW, Weinstein MJ, Weintraub RM et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med1986; 314: 1402-1406.
4.
van der Salm T., Ansell JE, Okike ON et al. The role of epsilon amino caproic acid in reducing bleeding after cardiac operations: a double-blind study. J Thorac Cardiovasc Surg1988 ; 95: 538-40.
5.
Del Rossi AJ , Cernairnu AC, Botros S., Lemole GM, Moore R.Prophylactic treatment of postperfusion bleeding with epsilon amino caproic acid. Chest1989; 96: 27-30.
6.
Horrow JC, Hlavacek J., Strang MD et al . Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg1990; 90: 70-74.
7.
Royston D., Bidstrup BP, Taylor KM, Sapsford RNEffect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet1987; ii: 1289-91.
8.
Fritz H., Wunderer G.Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforsch1983; 33(1 ): 4: 479-94.
9.
Kraut E., Frey EK, Werle E.Über die Inaktivierung des Kallikreins. Hoppe-Seyler's Zeitschrift für Physiologische Chemie1930; 192: 1-21.
10.
Kunitz M., Northrop JHIsolation from beef pancreas of crystalline trypsinogen, trypsin, atrypsin inhibitor and an inhibitor trypsin compound. Journal of General Physiology1936; 19: 991-1007.
11.
Royston D., Minty BD, Wallwork J., Higenbottam T., Jones JGThe effects of surgery with cardiopulmonary bypass on alveolar-capillary barrier function in man. Ann Thorac Surg1985; 40: 133-42.
12.
Royston D., Braude S., Nolop KB, Hughes Jmb.113m Indium protein flux does not reflect degree or outcome in respiratory failure. Am Rev Respir Dis1989; 139: A380.
13.
Royston D., Fleming JS, Desai JB, Westaby S., Taylor KMIncreased peroxide product generation associated with open heart surgery: evidence for free radical generation. J Thorac Cardiovasc Surg1986; 91 : 759-66.
14.
Braude S., Nolop KB, Fleming JS, Krausz T., Taylor KM, Royston D.Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass: association with lung neutrophil sequestration and tissue peroxidation . Am Rev Respir Dis1986; 134: 867-2.
15.
Clasen C., Jochum M., Mueller-Esterl W.Feasibility study of very high dose aprotinin in polytrauma patients . In: Schlag G, Redl H eds, First Vienna shock forum: pathophysiological role of mediators and mediator inhibitors in shock . New York: Alan R Liss Inc., 1987: 175-83.
16.
van Oeveren W., Jansen NJ, Bidstrup BP et al.Effects of aprotinin on haemostatic mechanisms during cardiopulmonary bypassAnn Thorac Surg1987; 44: 640-45.
17.
Bidstrup BP , Royston D., Sapsford RN, Taylor KMReduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol)J Thorac Cardiovasc Surg1989; 97: 364-72.
18.
Fraedrich G. , Weber C., Bernard A., Hettwer A., Schlosser V.Reduction of blood transfusion requirement in open heart surgery by administration of high dose aprotinin-preliminary results. Thorac Cardiovasc Surg1989 ; 37: 89-91.
19.
Dietrich W. , Barankay A., Dilthey G. et al. Reduction in homologous blood requirement in cardiac surgery by intraoperative aprotinin application clinical experience in 152 cardiac surgical patients . Thorac Cardiovasc Surg1989; 37: 92-98.
20.
van Oeveren W., Harder MP, Roozendaal KJ, Eijsman L., Wildervuur Crh.Aprotinin protects platelets against the initial effect of cardiopulmonary bypass . J Thorac Cardiovasc Surg: in press.
21.
National Institutes of Health.Perioperative red cell transfusion. National Institutes of Health Consensus Development Conference Statement, 1988: 7(4).
22.
Hannekum A., Reuter HD, Dalichau H., Horpacsy C., Selbherr J.Arilage und zusammenfassendes Ergebnis einer klinischen Doppelblindstudie bei Operationen am offenen Herzen. Einfluss von Aprotinin auf Thrombozytenzahl und -funktion. In: Dudziak et al. eds, Proteolyse und Proteinasen-inhibition in der Herz- und Gefässchirurgie . Stuttgart, New York: Schattauer, 1985: 222-33.
23.
Popov-Cenic S. , Murday H., Kirchhoff PG, Hack G., Fenyes J.Anlage und zusammenfassendes Ergebnis einer klinischen Doppelblindstudie bei aorto-koronaren Bypass-Operationen . In: Dudziak et al. eds, Proteolyse und Proteinasen-inhibition in der Herz- und Gefässchirurgie. Stuttgart, New York: Schattauer, 1985: 171-86.
24.
Murday H., Orellano L., Fenyes J., Popov-Cenic S., Kirchoff PGSind postoperative Blutungen in der Herzchirurgie durch Behandlung mit Aprotinin bzw.C1 inhibitor vermeidbar?Thorac Cardiovasc Surg1984; 44: 88.
25.
Royston D.The serine antiprotease aprotinin (Trasylol): a novel approach to reduce postoperative bleeding. Coagulation and Fibrinolysis; in press.
26.
Neuhaus P., Bechstein WO, Lefebre O., Blumhart G., Slema K.Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet1989 ; ii: 924-25.
27.
Dietrich W. , Jochum M., Schramm W., Blü mel G., Richter JAReduction of homologous blood requirement in cardiac surgery using high dose aprotinin . Anesthesiology1989; 71 (Supp): A7.
28.
Royston D., Bidstrup BP, Taylor KM, Sapsford RNReduced blood loss following open heart surgery with aprotinin (Trasylol) is associated with an increase in intraoperative ACT. J Cardiothorac Anesth1989; 3(Supp 1): 80.
